Skip to main content
Log in

Streptomyces sp. MNP32, a forest-dwelling Actinomycetia endowed with potent antibacterial metabolites

  • Original Article
  • Published:
3 Biotech Aims and scope Submit manuscript

Abstract

The Actinomycetia isolate, MNP32 was isolated from the Manas National Park of Assam, India, located in the Indo-Burma biodiversity hotspot region of Northeast India. Morphological observations and molecular characterization revealed its identity to be Streptomyces sp. with a 99.86% similar to Streptomyces camponoticapitis strain I4-30 through 16S rRNA gene sequencing. The strain exhibited broad-spectrum antimicrobial activity against a wide range of bacterial human pathogens including WHO-listed critical priority pathogens such as methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter baumannii. The ethyl acetate extract was found to disrupt the membrane of the test pathogens which was evidenced through scanning electron microscopy, membrane disruption assay and confocal microscopy. Cytotoxicity studies against CC1 hepatocytes demonstrated that EA-MNP32 had a negligible effect on cell viability. Chemical analysis of the bioactive fraction using gas chromatography-mass spectrometry (GC–MS) showed the presence of 2 major chemical compounds that include Phenol, 3,5-bis(1,1-dimethylethyl)- and [1,1ʹ-Biphenyl]-2,3ʹ-diol, 3,4ʹ,5,6ʹ-tetrakis(1,1-dimethylethyl)- which have been reported to possess antimicrobial activity. The phenolic hydroxyl groups of these compounds were proposed to interact with the carbonyl group of the cytoplasmic proteins and lipids leading to destabilization and rupture of the cell membrane. These findings highlight the potential of exploring culturable actinobacteria from the microbiologically under-explored forest ecosystem of Northeast India and bioactive compounds from MNP32 which can be beneficial for future antibacterial drug development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Data availability

The partial 16S rRNA gene sequence has been submitted to NCBI GenBank database and is available under the accession number - OP278937.

References

Download references

Acknowledgements

The authors would like to acknowledge the Department of Biotechnology, Government of India, and the Director of the Institute of Advanced Study in Science and Technology (IASST), Assam, India, (an autonomous institute under the Department of Science and Technology, Government of India) for providing the necessary facilities for the work. We would also like to acknowledge the electron microscopy facility and confocal imaging facility at Sophisticated Analytical Instruments Facility (SAIF) at IASST, Guwahati, Assam, for providing the necessary facility.

Funding

This work was supported by the Department of Biotechnology, Government of India (Grant number BT/PR25029/NER/95/967/2017), Department of Biotechnology, Ministry of Science and Technology, India.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Debajit Thakur.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Human and animal rights

The work did not involve any experiments which included human or animal subjects.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Konwar, A.N., Basak, S., Devi, S.G. et al. Streptomyces sp. MNP32, a forest-dwelling Actinomycetia endowed with potent antibacterial metabolites. 3 Biotech 13, 257 (2023). https://doi.org/10.1007/s13205-023-03670-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13205-023-03670-4

Keywords

Navigation